Haleon plc (LON:HLN) Insider Acquires £86,265 in Stock

Haleon plc (LON:HLNGet Free Report) insider Marie-Anne Aymerich bought 21,300 shares of the stock in a transaction dated Friday, May 9th. The shares were bought at an average cost of GBX 405 ($5.39) per share, with a total value of £86,265 ($114,805.70).

Haleon Trading Up 1.8%

Shares of LON:HLN opened at GBX 401.60 ($5.34) on Friday. The stock has a market capitalization of £36.25 billion, a PE ratio of 33.78, a P/E/G ratio of 1.49 and a beta of 0.19. Haleon plc has a 1 year low of GBX 319.84 ($4.26) and a 1 year high of GBX 417.70 ($5.56). The firm has a fifty day moving average price of GBX 385.73 and a 200 day moving average price of GBX 381.02. The company has a current ratio of 0.84, a quick ratio of 0.93 and a debt-to-equity ratio of 53.36.

Haleon (LON:HLNGet Free Report) last released its quarterly earnings results on Friday, February 28th. The company reported GBX 15.80 ($0.21) earnings per share (EPS) for the quarter. Haleon had a net margin of 9.66% and a return on equity of 6.54%. Analysts expect that Haleon plc will post 19.5033282 EPS for the current fiscal year.

Haleon Increases Dividend

The business also recently declared a dividend, which will be paid on Thursday, June 5th. Stockholders of record on Thursday, April 24th will be paid a dividend of GBX 4.60 ($0.06) per share. This is a boost from Haleon’s previous dividend of $2.00. This represents a dividend yield of 1.18%. The ex-dividend date is Thursday, April 24th. Haleon’s dividend payout ratio is 50.46%.

Analyst Ratings Changes

Separately, Berenberg Bank upped their target price on Haleon from GBX 456 ($6.07) to GBX 457 ($6.08) and gave the stock a “buy” rating in a research report on Friday, February 28th.

View Our Latest Analysis on Haleon

About Haleon

(Get Free Report)

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.

Read More

Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.